SE0201880D0 - Komposition för att behandla hudåkommor och för att förbättra hårtillväxt - Google Patents

Komposition för att behandla hudåkommor och för att förbättra hårtillväxt

Info

Publication number
SE0201880D0
SE0201880D0 SE0201880A SE0201880A SE0201880D0 SE 0201880 D0 SE0201880 D0 SE 0201880D0 SE 0201880 A SE0201880 A SE 0201880A SE 0201880 A SE0201880 A SE 0201880A SE 0201880 D0 SE0201880 D0 SE 0201880D0
Authority
SE
Sweden
Prior art keywords
composition
hair growth
skin conditions
treating skin
improving hair
Prior art date
Application number
SE0201880A
Other languages
English (en)
Inventor
Milenca Gardovic
Original Assignee
Milenca Gardovic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milenca Gardovic filed Critical Milenca Gardovic
Priority to SE0201880A priority Critical patent/SE0201880D0/sv
Publication of SE0201880D0 publication Critical patent/SE0201880D0/sv
Priority to PCT/SE2003/001029 priority patent/WO2004000305A1/en
Priority to AU2003237742A priority patent/AU2003237742A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0201880A 2002-06-19 2002-06-19 Komposition för att behandla hudåkommor och för att förbättra hårtillväxt SE0201880D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0201880A SE0201880D0 (sv) 2002-06-19 2002-06-19 Komposition för att behandla hudåkommor och för att förbättra hårtillväxt
PCT/SE2003/001029 WO2004000305A1 (en) 2002-06-19 2003-06-18 Composition for the treatment of skin diseases and for improving hair growth
AU2003237742A AU2003237742A1 (en) 2002-06-19 2003-06-18 Composition for the treatment of skin diseases and for improving hair growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201880A SE0201880D0 (sv) 2002-06-19 2002-06-19 Komposition för att behandla hudåkommor och för att förbättra hårtillväxt

Publications (1)

Publication Number Publication Date
SE0201880D0 true SE0201880D0 (sv) 2002-06-19

Family

ID=20288240

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201880A SE0201880D0 (sv) 2002-06-19 2002-06-19 Komposition för att behandla hudåkommor och för att förbättra hårtillväxt

Country Status (3)

Country Link
AU (1) AU2003237742A1 (sv)
SE (1) SE0201880D0 (sv)
WO (1) WO2004000305A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3238696A1 (en) * 2007-10-10 2017-11-01 Therametics, Llc Methods and compositions for treating dermatological diseases and conditions
US9616006B2 (en) 2007-10-10 2017-04-11 DermaMedics, LLC Methods and compositions for treating dermatological diseases and conditions
JP6417514B2 (ja) * 2017-09-13 2018-11-07 国立大学法人九州大学 ヘアケア製品の生産方法、毛母細胞増殖促進剤、毛乳頭細胞増殖促進剤及びメラニン生成促進剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147770A (en) * 1976-12-27 1979-04-03 Scholl, Inc. Preparation for treating dermatitis in the nature of tinea pedis
JPS59216817A (ja) * 1983-05-24 1984-12-06 Hamari Yakuhin Kogyo Kk 抗潰瘍剤
FR2566661A1 (fr) * 1984-07-02 1986-01-03 Gendler El Methode pour dissoudre la griseofulvine en vue de preparer une solution de cette substance pour applications locales, qui soit chimiquement stable et douee d'activite biologique
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
DE29923781U1 (de) * 1999-12-01 2001-08-30 Kundic Sida Mittel/Tinktur, kosmetische Produkte oder/und Arzneimittel zur Behandlung von Psoriasis

Also Published As

Publication number Publication date
WO2004000305A1 (en) 2003-12-31
AU2003237742A1 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
BR0206435A (pt) Composto, composição farmacêutica, métodos de tratar a angiogênese em um paciente, de tratar distúrbios relacionados com kdr e proliferativos em um mamìfero, uso de um composto, e, processo para preparar compostos
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
BR0107241A (pt) Compostos, processo de preparação dos compostos, uso dos compostos, composições fungicidas, processo de combate preventivo ou curativo dos fungos fitopatogênicos das culturas e método de tratamento preventivo ou curativo da madeira de construção
DE60118003D1 (de) Harnstoffderivate und ihre verwendung
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
ATE318267T1 (de) Einige alkylendiamin-substituierte heterocyclen
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
CY1105053T1 (el) Υποκατεστημενες ομοιαζουσες με ινδολιζινη ενωσεις και μεθοδοι χρησης
ES2191069T3 (es) Diaril-2-(5h)-furanonas como inhibidores de cox-2.
EA200500354A1 (ru) Новые оксазольные и тиазольные соединения в качестве ингибиторов трансформирующего фактора роста (тфр)
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
ATE190840T1 (de) Zusammensetzung zur behandlung der parkinson- krankheit
EA200500286A1 (ru) Новые изотиазольные и изоксазольные соединения в качестве ингибиторов трансформирующего фактора роста (тфр)
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
NO20054361L (no) Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
SE0201880D0 (sv) Komposition för att behandla hudåkommor och för att förbättra hårtillväxt
ATE432936T1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
ATE402694T1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
DE60027127D1 (de) Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen
IT1307786B1 (it) Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.